Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-phenylbenzimidazole-5-sulfonic Acid
2. 2-phenylbenzimidazole-5-sulfonic Acid, Monosodium Salt
3. Eusolex 232
4. Novantisol
5. Phenylbenzimidazole Sulfonic Acid
6. Phenylbenzimidazole Sulphonic Acid
1. 27503-81-7
2. 2-phenylbenzimidazole-5-sulfonic Acid
3. Phenylbenzimidazole Sulfonic Acid
4. 2-phenyl-1h-benzo[d]imidazole-5-sulfonic Acid
5. 2-phenyl-5-benzimidazolesulfonic Acid
6. 1h-benzimidazole-5-sulfonic Acid, 2-phenyl-
7. 2-phenyl-1h-benzo[d]imidazole-6-sulfonic Acid
8. 2-phenyl-1h-benzimidazole-5-sulfonic Acid
9. 2-phenyl-3h-benzimidazole-5-sulfonic Acid
10. Parsol Hs
11. 2-phenyl-1h-benzimidazole-5-sulphonic Acid
12. 9yq9di1w42
13. 1h-benzimidazole-6-sulfonic Acid, 2-phenyl-
14. Ncgc00166262-01
15. 1h-benzimidazole-5-sulfonic Acid-2-phenyl-
16. Dsstox_cid_18852
17. Dsstox_rid_79408
18. Dsstox_gsid_38852
19. Ensulizole [inn]
20. Cas-27503-81-7
21. Ultraviolet Absorbent Uv-t
22. Unii-9yq9di1w42
23. Ensulizole [usan:usp:inn]
24. Einecs 248-502-0
25. 2-phenylbenzimidazole-5-sulfonicacid
26. Mfcd00053007
27. Pbsa
28. Ensulizole [mi]
29. Ensulizole (usp/inn)
30. Ensulizole [usan]
31. Ec 248-502-0
32. Ensulizole [mart.]
33. Ensulizole [usp-rs]
34. Ensulizole [who-dd]
35. Schembl16277
36. Phenylbenzimidazole-sulfonic-acid
37. Chembl1987518
38. Dtxsid3038852
39. Chebi:135132
40. Bdbm181124
41. Ensulizole [usp Monograph]
42. Bcp17614
43. Zinc6467621
44. Tox21_112381
45. Tox21_200995
46. Bbl028055
47. S4419
48. Stk034479
49. 2-phenylbenzimidazole-5-sulphonic Acid
50. Akos005381771
51. Akos006029164
52. Parsol Hs 100 Microg/ml In Methanol
53. Tox21_112381_1
54. Us9138393, 2-phenyl Benzimidazole
55. Us9144538, 2-phenyl Benzimidazole
56. Ccg-245160
57. Db11115
58. 2-phenylbenz-imidazole-5-sulphonic Acid
59. Ncgc00166262-02
60. Ncgc00166262-03
61. Ncgc00258548-01
62. Ac-11988
63. As-12559
64. 2-phenylbenzo[d]imidazole-5-sulfonic Acid
65. Db-021496
66. Hy-109654
67. 2-phenyl-3h-benzimidazol-1-ium-5-sulfonate
68. 2-phenyl-5-benzimidazolesulfonic Acid, 96%
69. Cs-0033783
70. Ft-0613323
71. P1670
72. 2-phenyl-1h-1,3-benzodiazole-6-sulfonic Acid
73. D10005
74. H11816
75. Phenylbenzimidazole Sulfonic Acid [inci]
76. Ab00090049-01
77. 503p817
78. A819096
79. Sr-01000883690
80. Q-200317
81. Q7181424
82. Sr-01000883690-1
83. 2-phenylbenzimidazole-5-sulfonic Acid [vandf]
84. Us9138393, 2-phenyl-5- Benzimidazole Sulfonic Acid
85. Z275232302
86. Ensulizole, United States Pharmacopeia (usp) Reference Standard
87. 2-phenyl-5-benzimidazolesulfonic Acid, Analytical Reference Material
88. 2-phenyl-7ah-benzimidazole-5-sulfonic Acid;2-phenylbenzimidazole-5-sulfonic Acid
89. Ensulizole(2-phenylbenzimidazole 5-sulfonic Acid), Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 274.30 g/mol |
---|---|
Molecular Formula | C13H10N2O3S |
XLogP3 | 2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 274.04121336 g/mol |
Monoisotopic Mass | 274.04121336 g/mol |
Topological Polar Surface Area | 91.4 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 414 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Indicated to be used as an UV-B-absorbing molecule in sunscreen formulations.
Ensulizole is a selective UV-B filter with little activity against UV-A wavelengths. _In vitro_, ensulizole oxidizes guanine bases upon photoexcitation by UV-B and may cause photodamage on DNA, proteins and lipids in the cellular context.
Ensulizole strongly absorbs UV-B wavelengths. It offers protection against UV-B-induced cyclobutane pyrimidine dimers. Based on the findings in vitro and in cellulo, ensulizole induces damage on the DNA, causes DNA strand breaks and photosensitizes the formation of oxidized guanines via type I and II photosensitization mechanisms following UV-A or UV-B irradiation. Ensulizole is capable of generating reactive oxygen species, including singlet oxygen upon photoexcitation.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ensulizole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ensulizole, including repackagers and relabelers. The FDA regulates Ensulizole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ensulizole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ensulizole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ensulizole supplier is an individual or a company that provides Ensulizole active pharmaceutical ingredient (API) or Ensulizole finished formulations upon request. The Ensulizole suppliers may include Ensulizole API manufacturers, exporters, distributors and traders.
click here to find a list of Ensulizole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ensulizole as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ensulizole API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ensulizole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ensulizole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ensulizole NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ensulizole suppliers with NDC on PharmaCompass.
Ensulizole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ensulizole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ensulizole GMP manufacturer or Ensulizole GMP API supplier for your needs.
A Ensulizole CoA (Certificate of Analysis) is a formal document that attests to Ensulizole's compliance with Ensulizole specifications and serves as a tool for batch-level quality control.
Ensulizole CoA mostly includes findings from lab analyses of a specific batch. For each Ensulizole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ensulizole may be tested according to a variety of international standards, such as European Pharmacopoeia (Ensulizole EP), Ensulizole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ensulizole USP).
LOOKING FOR A SUPPLIER?